throbber
gluorii/ze
`Gbemzktry
`Q3/z'ews
`
`
`
`-ume l
`
`1967
`
`Ember 2
`
`L'.\':-mr.=':-a- 3: "or:
`
`Paul
`
`rant
`
`./f.\'.Fo:‘I:1I('E:f.?!_01+‘_r,-
`._
`. Rtchardson
`_. Lagowski
`
`.
`
`a MAR-CEL DEKKER journal of advances
`
`Page 1 of 58
`
`Arkema Exhibit 1140
`
`

`
`FLUORINE CHEMISTRY REVIEWS
` ._j.
`
`Executive Editor
`
`PAUL TARRANT
`UNIVERSITY OF FLORIDA
`GAINESVILLE, FLORIDA
`
`Associate Editors
`
`R. D. RICHARDSON
`ORGANIC CHEMICALS DEPARTMENT
`E. I. DU PONT DE. NEMOURS 5:: COMPANY
`WILMINGTON, DELAWARE
`
`J. J. LAGOWSKI
`DEPARTMENT OF CHEMISTRY
`UNIVERSITY OF TEXAS
`AUSTIN, TEXAS
`
`Advisory Board
`
`0. GLEMSER
`INORGANIC (IHEMISTRY INSTITUTE
`OF THE UNIVERSITY. GOFTINGEN
`
`J. D. PARK
`UNIVERSITY OT’ COLORADO
`BOULIJER, COLORADO
`
`M. HUDLICKY
`
`D. SIANESI
`
`RESEARCH INSTITUTE OF PHARMACY
`AND BIOCHEMISTRY, PRAGUE’.
`
`!NST|TLa"l‘I-I "G, DOI‘-IEGANI"
`MONTEC.-\1'lNI-EDISON, MILAN
`
`I. L. KNUNYANTS
`INSTITUTE OF I-]E‘I‘l."I-IOORGANIC
`COMPOUNDS, MOSCOW
`
`E. C. STUMP, JR.
`PENINSULAR CHIEMRESEARCH,
`GAINESVILLE, FLORIDA
`
`INC.
`
`H. MURAMATSU
`GOVERNMENT INDUSTRIAL RESEARCH
`INSTITUTE, NAGOYA
`
`N. VOROSHZOV
`INSTITUTF. FOR ORGANIC CHEMISTRY
`NOVOSIBIRSK
`
`Pubiishcd in 2 numbers per volume at 210? N. Charles 51., Baltimore, Md. 2l2l8,
`by Marcel Dekker, Im:., 95 Madison Avenue, New York, N. Y. 10016
`
`Volume 1 (2 numbers) 196?: $16.50
`Foreign Postage, $1.00 per volume
`Subscription orders should he sent to the office of the Publishers
`
`COPYRI-3HT© 1967 BY Mmcm. DEKKER, mc.
`
`PRINTED IN U.S.A.
`
`Contributions to This journal Are Published Free of Charge
`
`Page 2 of 58
`
`Page 2 of 58
`
`

`
`Fluorine Chemistry Reviews. 1 (2).
`
`|97—252 (I967)
`
`FLUOROCARBON TOXICITY AND
`BIOLOGICAL ACTION
`.:_?_.
`
`J. Wesley CIayron, Jr.
`HASKELL LABORATORY FOR TOXICOLOGY AND INDUSTRIAL MEDICINE
`E. I. DU FONT DE NEMOURS AND COMPANY
`WILMINGTON, DELAWARE
`
`.
`. Introduction
`.
`.
`.
`. Fluoroalkanes
`A. Acute Inhalation Toxicity
`B. Biological Action of Fluoroalkanes
`C. Chronic Toxicity of Fluoroalkanes
`D. Toxicity—Oral. Skin, and Eye
`. Fluoroalkenes
`.
`. Fluoropolymers
`. Conclusions
`References
`
`.
`
`I. INTRODUCTION
`
`Dominant among the chemical properties of the class of chemical com-
`pounds known as the fluorocarbons is their relatively high stability, a func-
`tion of the short interatornic distance between carbon and fluorine and the
`strength of the bond joining the two. The presence of fluorine in the mole-
`cule can exert profound influence. For example, in the chlorofluorocarbons
`fluorine stabilizes adjacent C—-Cl bonds and reduces the steric strain pro-
`duced by the relatively voluminous chlorine atoms. Furthermore,
`the
`accumulation of fluorine atoms on a carbon chain culminates in a changed
`bond energy and length between carbon and fluorine. Table 1 contrasts the
`bond length and energy of the C—Cl and C——F links in a series of fluoro-
`alkanes in which fluorine replaces chlorine. The perfluorinated member of
`this series reveals a significant bond shortening and energy increase com-
`pared to the compounds with a smaller complement of fluorine.
`I91
`
`Page 3 of 58
`
`Page 3 of 58
`
`

`
`I93
`
`J. Wesley Clayton. Jr.
`
`In considering the toxicology of the fluorocarbons, it is natural to relate
`the chemical properties outlined above to the biological action resulting from
`contact with living systems, and it appears that the stability of the C——F
`bond is probably the most important consideration. There is no need in this
`context to distinguish among the various kinds of bond scission which may
`be involved in specific instances. The important feature is the relative high
`
`TABLE 1
`
`Bond Length and Energy in Chlorofiuoromethanes“
`
`Compound
`
`CCL.
`CCl3F
`CCl;F;
`CCIF3
`CF;
`
`Bond length, A
`C—F
`C-CI
`
`Bond energy, kcal
`C—F
`C—Cl
`
`—
`1.348
`1.340
`1.328
`I .3] T
`
`1.765
`[.770
`1.77?
`1.135
`—
`
`—-
`ll2.1
`112.9
`ll4.6
`l I 6.0
`
`78.3
`17.7
`77.1
`76.5
`—
`
`" Based on data from G. Gloclter. J. Chem. Phys., 63, 828 (1959).
`
`order of'C—F bond stability. This bond afiinity may be adduced to explain
`the lack of biological action or, in contrast, a positive response. Lack of
`biological activity relating to C—F stability can be demonstrated by the
`fluoroanalogues
`of
`the
`sulfur mustards,
`S(CH2—-CI-I;Cl)2
`and
`S(CH1—-CH2F)2.
`The chloro compound is a potent vesicant caused by dissociation of the
`covalently bonded labile, chlorine fragment which leaves the highly active
`halogen-free moiety (1). It should be noted that it is not the released chlo-
`rine which causes the vesicant activity. The fluoro analogue, incontrast, is
`inoffensive, owing to firm C—F bonds which do not easily dissociate.
`Illustrating a positive response is the now classical lethal synthesis in
`which the C——-F bond of cu-fluoroacetate is refractory to enzymatic dehalo-
`genation. Fluoroacetate enters the tricarboxylic acid cycle with the C——F
`bond intact and passes without detectable interference to fiuorocitric acid
`(Fig. 1). At this point evidently steric hindrance precludes the action of the
`enzyme aconitase so that the next step in the chain, conversion to aconitic
`acid, is blocked. A major part of the toxicity of w-fluoroacetate, and com-
`pounds metabolized to it, is undoubtedly a result of blocked metabolism,
`and the strong C—-F union would seem to be the underlying cause. However,
`there is a considerable variation in the quantitative aspects and the kind of
`
`Page 4 of 58
`
`Page 4 of 58
`
`

`
`Fluorocarbon Toxicity and Biological Action
`
`ATP)
`
`ADP
`
`(HS—A(coenzvme A)
`®”—A)
`If
`(Cl-i1C00H
`F
`I
`CH ,—co-- S—A
`
`®—0H
`
`-
`
`1
`FCH
`1
`COOH
`{fluorocitrate)
`FIG. 1. Lethal synthesis. fiuoroaoetate to fluorocitrate.
`response shown by various animals which have received fiuoroacetate or its
`analogues. In the first place there is a wide range in the dose which proves
`lethal to a variety of vertebrate species. Table 2 summarizes data on acute
`toxicity of fluoroethanol, sodium fluoroacetate, or methyl fluoroacetate.
`The values for lethal dosages derived from graded intraperitoneal dosages
`range from <0.05 rngfkg for the pocket gopher to >500 mgflcg for the clawed
`TABLE 2
`
`Biological Response of Animals Receiving Intraperitoneal Injections of Fluoroethanol
`or Sodium or Methyl Fluoroaoetate
`__::
`Lethal dose,“
`
`mglkg
`Species
` _
`Pocket gopher
`<0.0S
`Kangaroo rat
`0.1
`Guinea pig
`0.35
`Ground squirrel
`0.9
`Hamster
`3.0
`Albino rat
`5.0
`Albino mouse
`10.0
`South African clawed toad
`>500
`
`" All figures represent the LDSO with the exception of the pocket gopher, which shows
`the LDm,.
`
`Page 5 of 58
`
`(fiuoroacetate)
`
`CO0!-I
`I
`+ H-OH
`(‘in
`C(0l-DCOOH
`
`CO0]-I
`
`lC
`
`H,
`
`IC
`
`(OH )COOH
`
`Page 5 of 58
`
`

`
`200
`
`J. Wesley Clayton. Jr.
`
`toad. In the second place the manner of response to administered fluoro-
`acetate is diverse among animals. The rat reflects the action of fiuoroacetate
`principally on the respiratory system, while the dog and rabbit register,
`respectively, central nervous and cardiovascular effects for the most part.
`The monkey and man show a combination of the three types of responses,
`indicating attack on several fronts. It is inferred from this diversified reac-
`tion among mammalian species that there is a generalized effect on tissue
`metabolism, with differences in prominence attributable to specific modes of
`entry or otherwise explicable at the cellular level, as disclosed by the obser-
`vations which follow.
`
`Metabolically, the Wistar rat turns over acetate at a lower rate than the
`Sprague-Dawley strain. Thus, the latter is more sensitive to alterations in
`acetate metabolism, and consequently fluoroacetate is more toxic for the
`Sprague-Dawley rat compared to the Wistar rat. The guinea pig brain
`actively oxidizes acetate; rabbit brain tissue does not. In the rabbit the heart
`takes up acetate avidly. These in vitro metabolic affinities correlate well with
`the convulsions experienced by guinea pigs and the cardiac arrest of rabbits
`given fluoroacetate.
`Additional inquiry into the biochemical pharmacology of fluoroacetate
`has been directed toward the cellular events which culminate in the animals‘
`response. In a review ofthis area Pattison and Peters (2) have considered the
`relationship between fluoroacetate and convulsions shown by some species.
`Fluoroacetate would seem not to be the direct cause ofconvulsions, as direct
`injection even of large doses into the subarachnoid space of the brain is
`without effect on the rat, pigeon, and rabbit. Fluorocitrate, however,
`is
`quite active, approximately 1.5 mg causing convulsions in the rat and 11 mg
`in the pigeon. The latter finding is consistent with the inability of pigeon
`brain tissue to convert fluoroacetate to fluorocitrate in vitro. The immediate
`cause for the convulsive response of the central nervous system has not yet
`been demonstrated. Pattison and Peters speculate that citrate accumulation
`resulting from fluorocitrate‘s inhibition ofaconitase may disturb the neural
`membrane equilibrium of divalent ions such as Ca“, with a resultant lower-
`ing of membrane potential and excitation. However, even though injected
`Ca“ depressed initial excitation induced by fluorocitrate, it was ineffective
`against subsequent severe convulsions. Thus,
`the cellular events which
`follow the interaction of fluorocitrate and aconitase, presumably the bio-
`chemical lesion, and the correlation of these with the reaction ofthe animal
`(e.g., convulsions, cardiac arrest} have yet to be elucidated.
`An important lesson from the two decades of effort that have been ex-
`pended in the attempt to explain the mechanism of fluoroacetate toxicity is
`
`Page 6 of 58
`
`Page 6 of 58
`
`

`
`Fluorocarbon Toxicity and Biological Action
`
`20I
`
`the potential amount ofwork involved in this kind of problem. With most of
`the fiuorocarbons only the first step in defining the toxicity has been taken.
`The handling of these materials by the body and the mechanisms of action
`have only recently been broached, or studies have not yet been initiated.
`Therefore, for many ofthe compounds cited in this review, as well as others
`on the same subject [Hodge et al. (3)], only preliminary toxicity data are
`available. It is a toxicological objective to understand the mode of action in
`relation to chemical constitution, and this should be a governing factor in
`future investigations on fluorocarbon toxicity.
`It is the objective of this paper to review the toxicology of the fluoro-
`carbons, including fluoropolymers, and to discuss some aspects of their bio-
`logical actions.
`
`II. FLUOROALKANES
`
`A. Acute Inhalation Toxicity
`
`This group of fluorocarbons is probably the most important at present
`from the commercial point of view. Fluoroalkanes are used as refrigerants,
`propellants, dielectric agents, fire extinguishing compounds, and food freez-
`ing materials. In general these are nonreactive compounds with high chemi-
`cal stability due to the strong C—F bond. This is undoubtedly the cause for
`the low toxicity ofthis class ofcompounds. Yet, while C—F firmness ensures
`stability and favors low toxicity, it does not imply complete lack of bio-
`logical activity. For example, trifluoroiodomethane, tagged with '3‘ I, may be
`safely used to trace the circulatory paths ofthe brain—demonstrating that,
`while the compound undergoes no detectable biological degradation, it is
`biologically active in penetrating the blood-brain barrier. A similar situation
`appears to obtain for fluorinated anesthetics in which metabolic degradation
`is not a sine qua non for the narcotic activity. The picture is much the same
`for other fluoroalkanes-—they are low in toxicity but biologically active, and
`probably for different reasons.
`Three developments reflect the increasing importance of knowledge ofthe
`toxicity of the fluoroalkanes. The first was the advent in the 19205 of
`mechanical refrigeration. After investigation ofseveral candidates possessing
`the requisite stability and physical properties, dichlorodifiuorornethane,
`CCl2F2, was prepared by Midgley and i-lenne (4), specifically for refrigerant
`use. This compound not only provided the requisite temperature-pressure
`relationships, nonflammability, but also a low degree of inhalation toxicity
`as compared to S0; and NH3.
`The second development is indicated by the publication, in I928 by F.
`
`Page 7 of 58
`
`Page 7 of 58
`
`

`
`202
`
`Wesley Clayton. Jr.
`
`Lehmann (5), of experiments on the pharmacological action and influence
`of the trifluoromethyl-CF3 group. This was the first report involving a
`number of fiuorinated compounds possessing pharmacological activity.
`The third one was the synthesis ofa number of derivatives of cu-fluoro-
`
`acetates, which resulted from chemical warfare research during World War
`11. Wartime security obscured the development of other fluorocarbons, but
`just prior to this period a significant discovery was made ofthe first fluoro-
`polymer, Tefl0n* tetrafluoroethylene resin. This resin, because of its resis-
`tance to most reagents, was largely committed to atomic energy programs.
`The postwar era saw a decline ofthe toxic fluoroacetate compounds. except
`as pesticides, and an increase in the market place ofmultifluorinated organic
`compounds having high stability and low toxicity. In this postwar develop-
`ment the major fluorocarbon contributors have been the fluoroalkanes.
`especially as aerosol propellants and refrigerants. Since these compounds
`are gases at room temperature, the chieftoxicological hazard was from inha-
`lation. Accordingly. the lirst toxicity experiments were aimed at evaluating
`the briefexposure that a householder, refrigeration repairman, or fire fighter
`might encounter. The Underwriters Laboratories designed an inhalation
`study in which groups of 12 guinea pigs were exposed to a graded series of
`concentrations of the test compound. At each sampling time of 5 min,
`30 min,
`1 hour, and 2 hours, three guinea pigs, if surviving the exposure,
`were removed from the chamber for observation or pathological examina-
`tion of vital organs within a 2- to 10-day period after exposure. This work
`also included other refrigerants in use at the time, for example, ammonia
`and sulfur dioxide. The comparison provided by their inclusion was invalu-
`able in putting candidate refrigerants and propellants in perspective with
`existing materials.
`Studies on several r_efrigerant compounds in the decade 1931-194! led to a
`classification system which has been used to grade the safety of new com-
`pounds. In this system class 1 compounds are the most toxic, causing death
`or serious injury when inhaled continuously by guinea pigs at 0.5-1 .0 vol. %
`for 5 min, e.g., sulfur dioxide. Class 2 is composed of materials which are
`lethal or injurious to guinea pigs at concentrations of 0.5-1 .0% for 30-min
`exposure, e.g., ammonia and methyl bromide. Classes 3 and 4 are distin-
`guished by an exposure which proves toxic for guinea pigs at 2.0-2.5 ‘X, for
`I hour and 2 hours, respectively, e.g., carbon tetrachloride and chloroform
`(class 3) and dichloroethylene and methyl chloride (class 4). Class 6 is de-
`fined by a 2-hour exposure at 20% which does not produce injury to the
`guinea pigs, e.g., dichlorodifluoromethane, dichlorotetrafluoroethane,
`* Registered du Pont trademark for fluorocarbon resins.
`
`Page 8 of 58
`
`Page 8 of 58
`
`

`
`Fluorocarbon Toxicity and Biological Action
`
`203
`
`monobromotrifluoromethane. Classes 4-5, 5a. and 5b are not precisely
`defined; they accommodate compounds more toxic than those in class 6 but
`less toxic than class 4 materials, e.g., trichlorotrifluoroethane and methylene
`chloride (class 4-5), trichloromonofiuoromethane, chlorodifiuoromethane,
`and C02 (class Sa), ethane, propane, and butane (class Sb}.
`The primary purpose of this system was to gauge the acute inhalation
`hazard, and it is evident that the fiuoroalkanes are low in toxicity on the
`basis ofthe above groupings. Subsequent work has been confirmatory, and
`experience in the chemical industry attests to a low order of toxicity for man.
`Toxicological data, Underwriters class, and threshold limit values (TLV) of
`the American Conference of Governmental
`Industrial Hygienists are
`summarized in Table 3 for a number of fiuoroalkanes.
`TABLE 3
`
`Inhalation Toxicity of Fluoromethanes
`
`Exposure.
`
`C‘oncn.,
`"/Q
`
`Hr
`
`+ or —
`
`2.0
`10.0
`20.0
`20.0
`2.0
`10.0
`20.0
`20.0
`20.0
`2.0
`5.0
`10
`20
`
`l\J--Id!‘-3|‘-‘I'~Jl-l|\lt~Jl‘~JI*J-dtxl
`
`Structure
`
`CI-ICI3
`CHCIEF
`Cl-lClF;
`Cl-IF;
`CCL.
`cc1,F
`CCi;F;
`CCIF3
`CF;
`04,0
`CH2Cl;
`CHCl;F
`CCIZF;
`
`U.L.
`class“
`3
`4-5
`5
`6‘
`3
`5
`6
`6"
`6!‘
`4
`4-5
`4-—5
`6
`
`TLV”
`S0
`1000
`(I000)
`(1000)
`10
`1000
`1000
`(1000)
`(1000)
`100
`500
`I000
`1000
`
`' U .L. signifies Underwriters‘ classification. The higher the value, the lower the toxicity.
`** TLV is the threshold limit value assigned by the American Conference of Govern-
`mental Industrial Hygienists. 1964 values. Figures in parentheses indicate provisional
`values.
`'= Based on data from Haskell Laboratory.
`in view of the fact that TLV‘s are often used incorrectly as toxicity indices,
`it is important to put them in perspective. The first industrial hygienic
`standards for airborne contaminants proposed for some fiuoroalkanes by
`Cook (6) ranged from 5000 ppm for dichlorofluoromethane to 100,000 ppm
`
`Page 9 of 58
`
`Page 9 of 58
`
`

`
`204
`
`]. Wesley Clayton. Jr.
`
`for dichiorodifiuoromethane. The values were subsequently lowered to
`1000 ppm, not from toxicity considerations but on the premise that proper
`engineering standards dictates that no contaminant vapor should be allowed
`to exceed 1000 ppm on an 3-hour average. Only carbon dioxide has a TLV
`greater than I000 ppm, i.e., 5000 ppm. Thus, while the TLV of 1000 ppm is
`commensurate with the low toxicity of the fluoromethanes. its purpose is
`primarily for good housekeeping. Industrial experience has established its
`validity and utility.
`Much of the early toxicity work on the fluoroalkanes was purely taxo-
`nomic—the assignment ofindividual compounds to categories. Toxicology
`has developed no sound principle whereby the toxicity of individual com-
`pounds can be determined from chemical structure or properties. This
`applies in full to the fiuorocarbons. in spite of C—-F bond strength and its
`intramolecular stabilizing influence, these are not reliable in predicting
`toxicity. As toxicity data became available, however, a general principle
`emerged. Like other generalities in biological science, this one partakes of
`the same kind oflimitations in that special cases defy the generalization. The
`data assembled in Table 3 illustrate this principle——a lower degree oftoxicity
`corresponding with an increasing number of fluorine atoms in the molecule.
`All three groups, A, B, and C, of Table 3 reveal this with the most striking
`example evident in group B, comparing CCL, with CF4. The influence of"
`fluorine and its interactions with other atoms in the molecule is also appa-
`rent in this compilation. As shown by the contrasting toxicities of CHCI3
`and CHCl2F (group A), the substitution of even a single F atom for C1
`effects a strong lowering of‘ toxicity in the chlorofiuoroalkane. It is plausible
`in this instance that the fact that the stability ofthe Cl atoms are enhanced by
`the C—F bond imposes an intractability to enzymatic dehalogenation with
`concomitant lower toxicity. Addition of additional F atoms in group A
`shows a continued decline in toxicity. Group B provides similar evidence of
`this stabilizing force of F vis it vis CI in the methane series. Yet another
`feature relating to the principle under discussion is shown by group C. This
`is the interplay of‘ hydrogen, fluorine, and chlorine. The substitution of CI
`for H appears to lower toxicity; compare CH3Cl with CH3Cl2. However.
`additional chlorination (i.e., CHCI3 and CCI4) yields compounds as toxic as
`CH3Cl. The replacement of H in CHZCI2 and CHCl2F with F to give
`CHCIZF and CCl2F2, respectively, also eventuates in lowered toxicity. Thus,
`while it is sometimes true that increasing the Cl complement favors a de-
`crease in toxicity. fluorine is far more effective than chlorine. This may also
`be illustrated by a lower toxicity for CHEF; contrasted with Cl-l2CI2.
`Henne (7) reported no toxic effects in guinea pigs inhaling 20°/,, CHEF; for
`
`Page 10 of 58
`
`Page 10 of 58
`
`

`
`Fluorocarbon Toxicity and Biological Action
`
`205
`
`hours, whereas 2 ‘X, CHZCIZ was fatal in 2 hours. The compound, CHZCIF,
`is intermediate; a few per cent is toxic. Thus, the order of toxicity would be
`CI-12Cl2 > CH3ClF > CI-121:2.
`This stabilizing attribute ofF may also be noted in connection with bromine.
`Table 4 indicates the following toxicity trend: CBr2F2 > CBrC1F, > CBrF3.
`TABLE 4
`
`Acute Inhalation Toxicity ofFluoromet]1anes Containing Bromine
`
`Exposure
`
`Compound
`
`Animal
`
`CBrgF3
`CBl'C]Fg
`CB1'F3
`
`Rat
`Rat
`Rat
`
`Time,
`min.
`
`15
`1 5
`l 5
`
`Lethal concn.."
`vol. "/1,
`
`5.5
`32
`83
`
`" Vapor mixed with air.
`
`From this sequence it can be inferred that the brominated compounds are
`more toxic than chlorinated and that those highly fluorinated are least toxic.
`In discussing the toxicity ofhalogenated compounds, it is to be emphasized
`that it is not the fugitive halogen which is the toxic agent. For example, the
`displacement by enzymatic dehalogenation of Br from Cl-I 3Br results in
`TABLE 5
`
`Acute Inhalation Toxicity of Several Fluoroethanes
`
`Approximate lethal concn. #
`
`Structure
`
`Vol. 7,,
`
`Exp., hr
`
`CC]1F-—CCl3F
`CClF2—-CC];
`CCl;F——CClF;
`cc1F;—ccu-3
`CHCI1-—CF3
`CClF2—CHF;._
`CCIF;-—CF3
`CHF2-—CF,
`CF,—cF,
`
`1.5
`1.5
`I0
`>20
`3.5"
`>20
`>sob
`2-I0
`>30b
`
`«F-I3-J7-I9-P-M-P-In-It
`
`Animal
`Rat
`Rat
`Rat
`Guinea pig
`Rat
`Guinea pig
`Rat
`Rat
`Rat
`
`a l..C5u.
`5 80?/,, fluorocarbon and 20° ., 03.
`
`Page 11 of 58
`
`Page 11 of 58
`
`

`
`206
`
`J. Wesley Clayton. _|r.
`
`methylation of methionine and other su1fur—containing compounds in vivo,
`thereby producing toxic elTects(1). In this regard CH3Cl is not as active as
`CI-l3Br, and, as would be anticipated, CH3}? is the least active of the three;
`thus, toxicologically the order is CH3Br > CH3CI > CH3F. Fluorination
`evidently imparts a resistance to dehalogenation, thus shielding the toxe-
`phoric part ofthe molecule.
`A correspondence oflow toxicity with increasing fluorination is disclosed
`by inhalation experiments with fiuoroalkanes of longer chain length. Table 5
`TABLE 6
`
`Comparison of Bromine and Chlorine in the Acute
`Inhalation Toxicity of Fluoroethancs
`
`Compound
`
`CH zCl—-C F 3
`CH2Cl—CI-IF;
`CH2Br—CF_,
`CH3Bt‘—CHFg
`
`" Mice exposed for I0 min.
`
`Lethal concn..°'
`vol. °/,,
`
`25.0
`1,5
`ll.7
`4.6
`
`summarizes relevant data on fluoroethanes, several having a chlorine com-
`plement, and Table 6 depicts the comparative roles of Cl and Br for fluoro-
`ethanc [compare CH2Cl—CF_; with CH2Br—CF3). In Table 6 the relation
`ofhydrogen and F is also evident from the comparison of'CH3Cl—CF3 with
`CHZCI-—CHF2 and CH2Br—CF3 with CH;,Br—CHF2. Table 7 summarizes
`the acute inhalation toxicity for several fluoropropanes. Again, the prin-
`ciple of declining toxicity with increasing fluorination is observed. The
`
`TABLE 7
`
`Toxicity of Several Fluoropropancs for Mice (exposed for 10 min)
`
`Structure
`
`Anesthetic
`concn., ‘if,
`
`Approx. lethal
`concn., ‘K
`
`HCF;—CI-l,—-CCIF;
`HCF;—CF;._—CBrF;
`HCF;—CF;,—CHC|F
`l-lCF3—CF;—Cl-ICI3
`CC|F;—CF2—CHgF
`CClF;—C‘F;._—Cl-IF;
`
`ID
`4
`2.5
`0.5
`10
`10
`
`20
`I0
`3
`2
`15
`20
`
`Page 12 of 58
`
`Page 12 of 58
`
`

`
`Fluorocarbon Toxicity and Biological Action
`
`207
`
`toxicity of octafluoroeyclobutane with a full complement of fluorine would
`seem the epitome of toxicological inertness, as Table 8 demonstrates.
`
`TABLE 8
`
`Toxicity Studies on Octafluorocyclobutane (0FCB}
`
`Exposure
` _—
`
`OFCB concn., Duration,
`vol. ‘Z,
`hr
`
`No. of
`exposures
`
`80“
`80“
`1.0
`10
`
`10
`
`0.25
`4
`6
`6
`
`6
`
`l
`1
`19
`4
`
`90
`
`Mice
`Rats
`Rats
`Rats, mice,
`guinea pigs, dogs
`Rats, mice,
`rabbits, dogs
`
`Toxic effects
`
`None
`None
`None
`None
`
`None
`
`“ 80% OFCB + 20% oxygen.
`
`B. Biological Action of Fluoroalkanes
`While it is important to gauge the toxicity ofa material by its lethal capa-
`city, it is equally important to evaluate the clinical and systemic responses to
`the agent. From the data on fluoroalkanes it is patent that the major res-
`ponse ofthe animals is mediated by the central nervous system. Indeed, the
`fact that many fluoroalkanes have been investigated as potential anesthetics
`sufliciently points up this attribute. l-(rantz and Rude (8) have recently re-
`viewed the clinical aspects of the fiuorinated anesthetics, and the reader is
`referred to this source for details which in the present paper can only be
`highlighted.
`Sayers et al. (9), in repeated exposures of dogs, monkeys, and guinea pigs
`to CCIZFZ, observed tremors and staggering gait in dogs and monkeys at
`20%. Booth and Bixby (I0) exposed mice to CHCIEF and Cl-ICIF2 and
`reported that concentrations of4 and 16 ‘X, caused convulsions; 20 and 49 %
`were lethal. Yant et al. (I I) reported incoordination and tremors in dogs but
`not in guinea pigs exposed 8, 16, and 24 hours at 15% CCIF2-—CClF2. In
`repeated exposures to 14.2"/,, CC1F2—-CCIF2, 8 hours daily, these authors
`observed signs of tremors, incoordination, and some convulsions for 3 to 5
`days in dogs. They then appeared to have developed a tolerance while expo-
`sures continued for 21 days. At 20 %, guinea pigs, which displayed no ner-
`vous system response at 14.2 "/,,, experienced tremors and convulsions but
`
`Page 13 of 58
`
`Page 13 of 58
`
`

`
`208
`
`J. Wesley Clayton. Jr.
`
`survived. Dogs died at 20 % after showing severe convulsions. Nuckolls (12),
`studying guinea pigs exposed to several fluorinated alkanes. noted loss of
`coordination in 2-hour exposures to CCl3F at a level ofabout 5 %, and severe
`tremors, anesthesia, and convulsions at l0 "4. Less marked signs of nervous
`system reaction were observed with CCIZFZ in exposures up to 30 %.
`Robbins ()3) investigated anesthetic response by mouse exposures on 12
`fluorinated derivatives of methane and ethane. He was able to eliminate
`unsatisfactory candidate anesthetics by convulsive responses provoked by
`some. Of those inducing only anesthesia, CHClBr—CF3 ultimately saw
`commercial development as halothanc. Subsequent clinical experience has
`validated these early animal experiments on halothane as a safe anesthetic in
`terms of its low degree of activity on the nervous system. Its relation to
`hepatotoxicity is discussed below.
`Lester and Greenberg ()4) studied five fluorinated alkanes, CCIZFZ,
`CH3—CHF,,, CH3—CClF2, CCl_=,F, and Cl-l2Br—CBrF-2, and have shown
`that the dominant clinical response in rats exposed for 30 min was narcosis,
`as evidenced by a disappearance of various reflexes with increasing concen-
`trations. Death, when occurring, appeared to be due to respiratory failure.
`Tremors and pulmonary irritation at anesthetic concentrations precluded
`additional exploration ofthese compounds as anesthetics for man.
`Burn (I5), and Burn et al. (16) have studied the anesthetic properties of
`three fluoroethanes: CCl2F—CCl2F, CC'.lF2—CCl2F, and CClF2—CHClF.
`The first two produced initial excitement and convulsions in mice during
`anesthesia at 1-2 % and 5-12 %, respectively. The third compound (note the
`presence of hydrogen) caused no deleterious neurological change during
`anesthesia at concentrations up to 7 ‘X, for 1 hour.
`Dishart (17), reporting on several fluorinated propanes, has shown a
`lowered anesthetic potency in mice for compounds which have more than
`four fluorine atoms. With these compounds high concentrations were
`required to produce anesthesia, but it was accompanied by convulsions. In
`fluoropropanes which produced satisfactory anesthesia,
`two of the four
`fluorine atoms had to be located on the central carbon, a position which
`conferred stability toward alkali and lack of toxic effects on the central
`nervous
`system of mice,
`for
`example, HCFZCFECHZCI
`and
`I-ICFZCFZCHZBL A higher degree of fluorination as in HCF3CF2CH2F,
`l-lCFzCF;CF2Cl, and HCF;CF2CF3Br or a lower chemical stability as in
`CF_:,CHBrCF3 provoked convulsant activity in mice in 10-min exposures or
`toxic effects possibly related to the instability of the compound in the body.
`Karpov (.-'8) studied eflects on the central nervous system's reactivity by
`chronic exposures of rabbits, rats, and mice to 14,200 or 1980 ppm of
`
`Page 14 of 58
`
`Page 14 of 58
`
`

`
`nObIIaCOr0INE:
`
`uhEXDT..
`
`V....
`
`nO.........CA.mKgb.mBdna
`
`mm..m<.r
`
`
`
`
`
`
`
`
`
`2:25mcozufizu_.m_h8ua..m_._ouozuoa9_uu.__=cu._.55...m:o_§.=:uu:oufiwr_.:_.___._.:_2..$m<m:_§=m_._E.m.£E..2€ao_m:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`.uE._o__._u.w.:3.ucm.=ooEo5.u_._m_.:oEoEo._n.u_.=E..oEoEo.E.u_.§=uE
`
`_._on_...mU-_vo._o=:m.:o._.-:.Eo=c_n_.Eo:c_.:..oE0._DO._o_._._U
`
`
`soum:.m_u.~..:muEcmu£50nrmfu2o_§_..;_
`
`EE2:383:c.__E...:83:amoufi.Ran.
`8o.........55as25.3.2:8959E3.555
`
`08.».owmfiau._u>_4
`
`89.2E.omscfi.556@9339
`
`E_E
`
`
`E5N:Sun.E5E83:2:5as89.:52:0:38Ems“Eam:__t__.£:5:
`
`EEom.Sq...GE3.Sod.E_Eedo8.8mAEEas8.3.$u:_..§o._Q
`
`E_E1.Sod8%LEE3ES._._o:u:_EoouE
`:.:E3oceanmT.SoaodmE0593Duos23¢Eam_._o_.m_:>uoU
`
`
`
`.mu3_._.._._u:u.n_Emcozumuc..oguano.63E:.a
`
`Page 15 of 58
`
`Page 15 of 58
`
`

`
`3%
`
`manu:_:D
`
`8:2
`
`:33.
`
`umconmumm:=2
`
`:62
`
`-35
`
`omconwum5:5
`
`umuenmom
`
`1oz
`
`282o:6
`
`Iuz
`
`aaz26
`
`282
`
`252
`
`E.E_=_m__m3:023
`
`_§_553.“2:926
`
`Emzm.b_>_5mon§_._
`
`
`
`:2:..._o:umo..
`
`_mE._o:
`
`
`
`:2:.:o_fimo._
`
`_m_._.io:
`
`U2
`
`
`
`EH:..9_>_.uaoa»I
`
`.._o_>E_oaE
`uacmcu
`
`
`
`Bo::o:EE$._
`
`
`
`32»:o_.E_n_mu..
`
`3%can
`
`.._o_>a_._BE
`omcmau
`
`-32
`
`5:3
`
`23
`
`3.5
`
`$2:
`
`uucoamum
`
`.52
`
`has
`
`902
`
`D2
`
`J. Wesley Clayton. Jr.
`
`
`
`E_.__.5___:vuum
`
`uu:o_o:Eom
`
`.uo.co_m._oEu.:uni
`
`
`
`2ENEOE»:.:o_§.:mo._m
`
`mmo_._m:o?_uZor;
`
`.:o_&u..anO
`
`zmw.uo:2o:Eom
`
`a_=uE_u
`
`
`
`mu.“E2.m._oEu.:
`
`mwazxnua
`
`
`
`vac.8_._a_o:Eowo_.6
`
`
`
`5.Sure.m.5Eu.:
`
`mmo:_u._§_:_3m5%E8E:tn____=uu
`
`
`
`one..$_._n@€
`
`
`
`noun.can
`
`.5_>:uno9n_._
`
`3.5
`
`
`
`...:oEu.:.m_mm_._EnE
`
`.m:o_£n>:ou_u_5
`
`mafia
`
`.moE_s.._:Eoxm
`
`N3
`
`N3
`
`.Ba=_=.88:.02a
`
`2.m_._..,_<._.
`
`
`
`
`
`u=s5oEo.5=c_.:aEo._m2EN.8:uomonxmm_mE__._<._oumconmum_.3_:__UE8_3=.mtOE
`
`
`
`
`
`Page 16 of 58
`
`Page 16 of 58
`
`

`
`Fluorocarbon Toxicity and Biological Action
`
`III
`
`CH CIFZ. Neurological studies, including swimming endurance, number of
`subthreshold impulses to produce a reflex, and number of trials to establish
`a conditioned response, revealed effects only at the lower level.
`Gage ([9) has compared several halogenated fire-extinguishing com-
`pounds, particularly observing neurological responses. Table 9 summarizes
`his findings. The most inactive of this group was bromotrifluoromethane.
`Paulet (20) has also reported his experiments on this compound (Table 10).
`Rabbits, mice, guinea pigs, and rats showed an increasing degree of neuro-
`logical effect in 2-hour exposures as the concentration of CBrF3 reached
`60 vol. "/,, and higher. Clearly, this is a fluoroalkane of low toxicity. Paulet
`observed death only at 80 7,, and above.
`It has been known for some time that certain hydrocarbons, notably cyclo-
`propane among inhalation anesthetics, can make the heart muscle abnorm-
`ally reactive to epinephrine, resulting in arrhythmic contractions. Krantz
`and Rudo (8) note that several halogenated alkenes possess this property of
`myocardial sensitization in addition to many straight chain and cyclic
`hydrocarbons. Perfluorinated compounds studied by these workers were
`inactive, but the chlorinated ones were active. Among the fluoroalkanes,
`recent work at Haskell Laboratory has shown that dogs inhaling CBrF3
`(5-10 vol.
`24,) or CCl2F——CClF2 (0.5—l.0 "/0) evidenced cardiac arrhyth-
`mia after intravenous injection of epinephrine. It is expected that perfiuori-
`nated alkanes would be inactive.
`In summary the dominant clinical response to inhaled fiuoroalkanes is
`neurological in character, varying from anesthetic to convulsive reactions.
`When death has occurred in animal studies, the principal anatomic finding
`has been pulmonary injury. The degree of fluorination appears to be related
`inversely to the reactions in the central nervous system which the clinical
`signs indicated.
`I-lalogenated alkanes as a class are noted for their hepatotoxicity. Effects
`on other organs are minimal and outside the scope of the present review.
`Outstanding hepatotoxins are several chlorinated compounds: carbon
`tetrachloride, chloroform, 1,2-dichloroethane, and symmetrical
`tetra-
`ehloroethane. On the other hand, fluorinated alkanes would not be con-
`sidered significant hepatotoxins, as illustrated by the following discussion.
`Lester and Greenberg (14) exposed rats to several concentrations (5-80 "/D)
`of CCl_~,F and CCIZFE for 30 min and of CCl2F2 for 4 and 6 hours. Liver
`injury was not observed in rats exposed to either compound, even when
`CCIZF; was inhaled at 80 “/0 for 4 and 6 hours. Other fluoroalkanes were con-
`sidered by these authors: CH3-—Cl-IF2, CH3——CClF2, and CHgBf—-CBTF2;
`in no case was the liver of exposed rats damaged.
`
`Page 17 of 58
`
`Page 17 of 58
`
`

`
`2l2
`
`J. Wesley Clayton. Jr.
`
`The compounds of CCl_;,F, CCIF3, and CF4 have been studied at Haskell
`Laboratory by single. 4-hour. rat or guinea pig exposures, and repeated ex-
`posures. Rats exposed to vapors of CCI3F in the range of 3.6 to l 1.8 “A ex-
`hibited a noninjurious vacuolation of the liver cells, a change which

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket